Agar Scientific has been acquired by Calibre Scientific
Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.
Agar is a global leader in the distribution and manufacture of electron microscopy consumables. The business was created as the result of an MBO carve out backed by Foresight Group in 2016. Since then, the firm has more than doubled in size under the stewardship of Darren Likely and the Agar management team. Agar has a strong strategic fit with Calibre, providing many synergy benefits. It will enable Calibre to expand their customer base and open up new markets in high growth areas.
Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, with an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth, its global reach extends into over 100 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.
Oaklins Cavendish, based in the UK, acted as advisor to Agar Scientific in this transaction.



Darren Likely
CEO, Agar Scientific Ltd.
Talk to the deal team
Related deals
Bolster Investment Partners has acquired a majority stake in Eternal Sun
Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.
Learn moreCerbios-Pharma has been acquired by HAS Healthcare
Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.
Learn moreiwell raises US$31 million to deploy its leading European smart battery storage solutions into new markets
iwell, a developer of smart energy management (EMS) and battery storage systems (BESS), has successfully closed a US$31 million (€27 million) funding round. The round was led by Meridiam, with Invest-NL and Rabobank participating, alongside existing investors.
Learn more